Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy.
- DOI
- 10.1007/s00520-026-10847-z
- Published
- 2026 Jun 2
- Container
- Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00520-026-10847-z,
title = {Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy.},
author = {Saif F and Qureshi FN and Ahmad A and Durrani F and Azam NUA and Ullah I and Ahmed ZUD and Khan AR},
year = {2026},
journal = {Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer},
doi = {10.1007/s00520-026-10847-z},
url = {https://doi.org/10.1007/s00520-026-10847-z}
}RIS
TY - JOUR TI - Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy. AU - Saif F AU - Qureshi FN AU - Ahmad A AU - Durrani F AU - Azam NUA AU - Ullah I AU - Ahmed ZUD AU - Khan AR PY - 2026 JO - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer DO - 10.1007/s00520-026-10847-z UR - https://doi.org/10.1007/s00520-026-10847-z ER -
APA
F, S., FN, Q., A, A., F, D., NUA, A., I, U., ZUD, A., & AR, K. (2026). Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. https://doi.org/10.1007/s00520-026-10847-z
Source records
- pubmed · retrieved 2026-09-26T22:09:04.999Z